Vietnam has launched clinical trials of a new antiviral drug that could offer fresh hope in the fight against dengue fever, a disease that still has no approved specific treatment worldwide.
In a recently published review, a research team led by MedUni Vienna has highlighted a promising new approach to drug discovery. The focus is on the targeted modulation of certain intracellular ...
Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the ...
The nanomedicine market is largely propelled by the increasing demand for precise and more effective treatments, especially for cancer, cardiovascular conditions, and other chronic diseases, where ...
Bioavailability data recently obtained from Phase 1 study with a stable crystal form of neflamapimod manufactured using a new, controlled ...
With our Phase IIa program underway and defined milestones in front of us, we look forward to engaging with investors and potential partners at BIO.” — Christer Rosén, Chairman and Chief Executive ...
The earliest stage of drug discovery is governed by a simple constraint: there are far more possible drug-like molecules than any pharmaceutical laboratory could ever test. A new deep learning system, ...
10d
Smart materials and drug delivery could exploit lipid molecules that reorganize at drying interfaces
Minor changes in moisture level can promote lipid molecules to reorganize themselves in biomaterial or biomembranes. This can ...
CEOCFO interviews NanOlogy, LLC CEO David J. Arthur on Solving Toxicity & Bioavailability Problems when Treating ...
Coming off a U.S. FDA approval of the first GLP-1 in pill format, Novo Nordisk A/S leaned further into oral drug delivery efforts, partnering with Vivtex Corp. to develop next-generation oral ...
Vivtex Corporation, launched in 2018 as a spinoff of the Massachusetts Institute of Technology (MIT), will license oral drug-delivery technologies to Novo for weight loss, diabetes, and related ...
This narrative review in the British Journal of Biomedical Science examines emerging and recently approved therapeutic strategies to combat antimicrobial resistance, spanning new antibiotics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results